{"id":62736,"date":"2026-03-04T16:06:42","date_gmt":"2026-03-04T15:06:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/childrens-minnesota-unveils-regions-first-dedicated-pediatric-neurointerventional-angiography-suite-to-treat-stroke-patients\/"},"modified":"2026-03-04T16:06:42","modified_gmt":"2026-03-04T15:06:42","slug":"childrens-minnesota-unveils-regions-first-dedicated-pediatric-neurointerventional-angiography-suite-to-treat-stroke-patients","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/childrens-minnesota-unveils-regions-first-dedicated-pediatric-neurointerventional-angiography-suite-to-treat-stroke-patients\/","title":{"rendered":"Children\u2019s Minnesota Unveils Region’s First Dedicated Pediatric Neurointerventional Angiography Suite to Treat Stroke Patients"},"content":{"rendered":"
\n

\nThe new suite brings advanced treatment options to pediatric patients with various types of strokes, including blood vessel malformations causing bleeding in the brain, as well as blood clots<\/i><\/p>\n

MINNEAPOLIS–(BUSINESS WIRE)–Children\u2019s Minnesota is pleased to announce a $2.5 million, state-of-the-art biplane neuroangiography suite\u2014the region\u2019s only facility dedicated to pediatric neurointerventional procedures. This advanced imaging technology brings new treatment options for children with a variety of cerebrovascular diseases, further expanding Children\u2019s Minnesota\u2019s neurosurgical capabilities.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\n\u201cWith this advanced biplane neuroangiography suite, we are raising the bar for children in our region impacted by a stroke or other cerebrovascular conditions,\u201d said Meysam Kebriaei, MD, medical director of neurosurgery at Children\u2019s Minnesota. \u201cBy becoming the regional referral program for complex pediatric cerebrovascular and stroke cases, we are ensuring no child has to travel farther than they should to get world-class care, and we’re building a future where our kids not only survive but thrive.\u201d<\/p>\n

\nThe suite delivers exceptionally detailed, three-dimensional images of blood vessels in and around the brain, allowing neurointerventional surgeons to diagnose and treat pediatric stroke, aneurysms, arteriovenous malformations, as well as brain tumors and other intracranial pathologies. <\/b>This advanced imaging capability enables Children\u2019s Minnesota\u2019s multidisciplinary team of kid experts to identify and characterize vascular blockages and other abnormalities with unmatched precision. Using these high-resolution images, neurointerventional surgeons can develop targeted treatment plans and perform minimally invasive interventions for complex conditions to minimize risk and improve outcomes.<\/p>\n

\n\u201cThis defines a new chapter in pediatric neurovascular care in the upper Midwest. We are very fortunate to have assembled one of the most experienced neurointerventional teams in the country right here in the Twin Cities. Our goal is to become one of the leading practices nationally and contribute our experience to the expanding field of pediatric neurointervention internationally through academic and service missions,\u201d said Collin Torok, MD, medical director of neurointerventional surgery at Children\u2019s Minnesota, and co-director of the cerebrovascular program with Dr. Kebriaei.<\/p>\n

\nThis added technology strengthens Children\u2019s Minnesota\u2019s cerebrovascular and stroke program<\/a>, making it one of only a few dedicated pediatric programs of its kind in the country with depth of experience, high-quality multidisciplinary treatments, long-term management and strong clinical outcomes for patients. The cerebrovascular and stroke program at Children\u2019s Minnesota brings together a team of pediatric experts to provide the most advanced level of care for kids and young adults.<\/p>\n

\nLearn more about the cerebrovascular and stroke program at Children\u2019s Minnesota<\/a>.<\/p>\n

\nOther highlights of the cerebrovascular program include:<\/p>\n